United-Guardian Inc represents strong core values and a clear corporate philosophy. The company is committed to providing superior products and services to its customers, focusing on customer satisfaction and long-term relationships. United-Guardian Inc prioritizes quality, innovation, and integrity in all aspects of its operations. With a history of over 75 years, the company has built a reputation for excellence and reliability. United-Guardian Inc strives to be a leader in its industry, continuously improving and adapting to meet evolving market demands. Through its dedication to its values and philosophy, United-Guardian Inc aims to deliver consistent value to its stakeholders and maintain its position as a trusted and respected stock in the market.

United-Guardian Inc is primarily present in the United States.

United-Guardian Inc. has achieved several significant milestones since its inception. The company has established a strong reputation in the pharmaceutical and personal care industries. Notably, United-Guardian Inc. developed and patented its highly effective pharmaceutical product called Renacidin®, used for treating and preventing catheter encrustation and blockage. The company has also made advancements in the field of personal care, creating innovative ingredients like Lubrajel®, a line of moisturizers used in cosmetics and skincare products. Additionally, United-Guardian Inc. has expanded its global reach by forming strategic partnerships and expanding distribution channels. These achievements showcase United-Guardian Inc.'s dedication to innovation and success in its respective industries.

United-Guardian Inc, founded in 1942, is a leading specialty chemical manufacturer based in the United States. The company specializes in the research, development, and production of pharmaceuticals, personal care ingredients, cosmetic ingredients, and health care products. With extensive experience and a strong reputation, United-Guardian has established itself as a trusted supplier to various industries worldwide. The company's commitment to innovation, quality, and customer satisfaction has enabled it to grow steadily over the years. Today, United-Guardian continues to provide innovative solutions and reliable products that meet the highest industry standards, making it a reputable and sought-after company in the market.

The main competitors of United-Guardian Inc in the market include companies such as Johnson & Johnson, Procter & Gamble, and Kimberly-Clark. These industry giants operate in the consumer goods sector and offer similar products and technologies. United-Guardian Inc faces competition in areas such as personal care products, pharmaceuticals, and medical devices. Despite a competitive market, United-Guardian Inc has managed to establish a strong foothold with its innovative product portfolio and a dedicated customer base.

United-Guardian Inc is primarily active in the pharmaceutical and personal care industries.

United-Guardian Inc is a company that specializes in the development, manufacturing, and marketing of cosmetic ingredients, pharmaceuticals, and personal care products. Their business model revolves around providing high-quality and innovative solutions to their customers in various industries. With a focus on research and development, United-Guardian Inc aims to create products that address specific needs and deliver exceptional results. Through their extensive portfolio and commitment to customer satisfaction, United-Guardian Inc has established itself as a trusted provider in the market, consistently delivering value to its clients.

Pašreizējais KGV United-Guardian nevar tikt aprēķināts.

KUV šobrīd United-Guardian nevar aprēķināt.

AlleAktien kvalitātes vērtējums United-Guardian ir 4/10.

Pašreiz nevar aprēķināt apgrozījumu United-Guardian.

Pašlaik peļņa United-Guardian nevar tikt aprēķināta.

United-Guardian Inc is a company that has been engaged in the development and production of pharmaceutical, cosmetic, and industrial products since 1942. The company is headquartered in New York and distributes its products worldwide. The business model of United-Guardian is focused on the production and sale of pharmaceutical and cosmetic ingredients that are used in many industries. The products are divided into four main areas: Pharmaceuticals, Cosmetics, Personal Care, and Industrial Applications. In the Pharmaceuticals segment, United-Guardian produces and distributes ingredients that are used in medicine, veterinary medicine, and the production of dietary supplements. These include potassium dihydrogen phosphate, sodium cyclamate, aluminum hydroxide, magnesium hydroxide, and sodium pyrosulfite. Production takes place in its own facilities and is controlled according to the highest quality standards. In the cosmetics industry, United-Guardian offers a variety of ingredients that are used in skincare, hair care, deodorants, and sunscreens. These include phenylbutyl acetate, dimethylpyrazine, and piroctone olamine. These ingredients are developed in close collaboration with customers and tailored to their needs. The Personal Care segment includes products such as shampoos, conditioners, and hair dyes that are used by customers worldwide. United-Guardian manufactures products based on natural ingredients and of high quality. This includes products like the Sanitized process, which reduces bacteria and fungi and improves the shelf life of cosmetics. The industrial segment of United-Guardian covers a wide range of applications. These include products such as polyvinyl acetate, ethyl cellulose, and methacrylic acid-methacrylate copolymer. These ingredients are used in applications such as adhesives, coatings, and lubricants, offering high quality and performance. Overall, the business model of United-Guardian is characterized by close collaboration with customers and high manufacturing competence. The production of high-quality ingredients and products for various industries is an important part of United-Guardian's business model. The company places a special focus on quality assurance and continuous improvement, as evidenced by its certification to ISO 9001 and ISO 14001. In summary, United-Guardian's business model is focused on the production of pharmaceutical, cosmetic, and industrial products. The company works closely with customers to develop products that meet their individual requirements. A special emphasis is placed on quality assurance and continuous improvement.

United-Guardian izmaksā dividendes 0,68 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt United-Guardian vai uzņēmums nedod dividendes.

United-Guardian ISIN ir US9105711082.

United-Guardian WKN ir 867399.

United-Guardian simbols ir UG.

Pēdējo 12 mēnešu laikā United-Guardian maksāja dividendes 0,20 USD apmērā. Tas atbilst aptuveni 1,49 % dividendes ražībai. Nākamajos 12 mēnešos United-Guardian plāno maksāt dividendes 0,20 USD apmērā.

United-Guardian pašreizējā dividendu rentabilitāte ir 1,49 %.

United-Guardian maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos decembris, augusts, marts, augusts.

United-Guardian pēdējo 20 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0,20 USD. Tas atbilst dividendes ražībai 1,49 %.

United-Guardian tiek piešķirts nozarei "Necikliskais patēriņš".

Lai saņemtu pēdējo dividendu United-Guardian apmērā 0,35 USD, kas tika izmaksāta 31.07.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 23.07.2024..

Pēdējās dividendes izmaksa notika 31.07.2024..

Gadā 2023, United-Guardian izmaksāja 0,68 USD dividendes.

United-Guardian dividendes tiek izmaksātas USD.